293 related articles for article (PubMed ID: 36117622)
1. Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease.
Coles M; Steiner-Lim GZ; Karl T
Front Neurosci; 2022; 16():962922. PubMed ID: 36117622
[TBL] [Abstract][Full Text] [Related]
2.
Watt G; Karl T
Front Pharmacol; 2017; 8():20. PubMed ID: 28217094
[TBL] [Abstract][Full Text] [Related]
3. Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review.
Cooray R; Gupta V; Suphioglu C
Mol Neurobiol; 2020 Nov; 57(11):4878-4890. PubMed ID: 32813239
[TBL] [Abstract][Full Text] [Related]
4. Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice.
Aso E; Sánchez-Pla A; Vegas-Lozano E; Maldonado R; Ferrer I
J Alzheimers Dis; 2015; 43(3):977-91. PubMed ID: 25125475
[TBL] [Abstract][Full Text] [Related]
5. A Critical Review of the Role of the Cannabinoid Compounds Δ
Jones É; Vlachou S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
Nahler G
Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
[TBL] [Abstract][Full Text] [Related]
8.
Viana MB; de Aquino PEA; Estadella D; Ribeiro DA; Viana GSB
Med Cannabis Cannabinoids; 2022; 5(1):207-219. PubMed ID: 36467781
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of Oxidative Stress by Cannabinoids and Cannabis Extracts in Differentiated Neuronal Cells.
Raja A; Ahmadi S; de Costa F; Li N; Kerman K
Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33105840
[TBL] [Abstract][Full Text] [Related]
11. A pharmacological characterization of Cannabis sativa chemovar extracts.
Devsi A; Kiyota B; Ouellette T; Hegle AP; Rivera-Acevedo RE; Wong J; Dong Y; Pugsley MK; Fung T
J Cannabis Res; 2020 May; 2(1):17. PubMed ID: 33526117
[TBL] [Abstract][Full Text] [Related]
12. The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer's Disease-like Mouse Model.
Kim J; Choi P; Park YT; Kim T; Ham J; Kim JC
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047798
[TBL] [Abstract][Full Text] [Related]
13. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
14. Effects of Chronic, Low-Dose Cannabinoids, Cannabidiol, Delta-9-Tetrahydrocannabinol and a Combination of Both, on Amyloid Pathology in the 5xFAD Mouse Model of Alzheimer's Disease.
Arnanz MA; Ruiz de Martín Esteban S; Martínez Relimpio AM; Rimmerman N; Tweezer Zaks N; Grande MT; Romero J
Cannabis Cannabinoid Res; 2023 Oct; ():. PubMed ID: 37862567
[No Abstract] [Full Text] [Related]
15. Cannabidiol for neurodegenerative disorders: A comprehensive review.
Bhunia S; Kolishetti N; Arias AY; Vashist A; Nair M
Front Pharmacol; 2022; 13():989717. PubMed ID: 36386183
[TBL] [Abstract][Full Text] [Related]
16. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer's Disease.
Hickey JP; Collins AE; Nelson ML; Chen H; Kalisch BE
Curr Issues Mol Biol; 2024 May; 46(5):4379-4402. PubMed ID: 38785534
[TBL] [Abstract][Full Text] [Related]
18. Use of Cannabis for Agitation in Patients With Dementia.
Mueller A; Fixen DR
Sr Care Pharm; 2020 Jul; 35(7):312-317. PubMed ID: 32600509
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of Cannabidiol but Not Δ
Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
Vann RE; Gamage TF; Warner JA; Marshall EM; Taylor NL; Martin BR; Wiley JL
Drug Alcohol Depend; 2008 Apr; 94(1-3):191-8. PubMed ID: 18206320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
